Johnson & Johnson (JNJ) Tops Q3 EPS by 7c; Boosts FY14 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Johnson & Johnson (JNJ) PT, Estimates Cut at BofA/Merrill Lynch Post Q3
October 15, 2014 7:23 AM EDTBofA/Merrill Lynch analyst Bob Hopkins lowered his price target on Johnson & Johnson (NYSE: JNJ) to $99.00 (from $106.00) while reiterated a Neutral rating following 'solid' Q3 results.
Hopkins said while solid the quarter also highlighted a number of likely EPS headwinds for... More
